Treme Bio
PrivateCompany Overview
Treme Bio operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. It was founded in 2026.
Treme Bio is a biotechnology company developing ProLymphNano, a patented drug delivery technology that focuses on the lymphatic system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treme Bio Comparables
Compare Treme Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evoq Therapeutics | 74% | |
| Ropirio Therapeutics | 69% | |
| Elicio Therapeutics | 69% |
For institutional investors. Book with your work email.
Treme Bio Funding Rounds
Historical fundraising activity
Treme Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Treme Bio's valuation, stock price, and market status.
Is Treme Bio a public or private company?
Treme Bio is a private company.
What is the current stock price of Treme Bio?
Treme Bio is a private company, so its shares have no public market price. Caplight tracks Treme Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Treme Bio worth (valuation)?
Valuation information for Treme Bio is not publicly available.
Can I buy Treme Bio stock?
Treme Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Treme Bio's last funding round?
Funding round information for Treme Bio is not publicly available.
Who are the main investors in Treme Bio?
Investor information for Treme Bio is not publicly disclosed.
Will Treme Bio IPO soon?
No public IPO plans have been announced for Treme Bio.
How can I track Treme Bio secondary market activity?
Caplight tracks bids, offers, and trades in Treme Bio's shares on secondary markets.